Drug: ATENOLOL. Injury: Gastrooesophageal reflux disease Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 81570958 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 22735.00 DY | M | 84 KG | 20160930 | US |
| 108805743 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 70.00 YR | F | 79 KG | 20160927 | US |
| 111304883 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 0.00 | F | 59 KG | 20160823 | US |
| 126279901 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 56.00 YR | M | 75 KG | 20160807 | US |
| 126873721 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 26356.00 DY | F | 133 KG | 20160826 | US |
| 127541501 | ATENOLOL. | Gastrooesophageal reflux disease | ASTRAZENECA | 0.00 | F | 48 KG | 20160916 | US |
Total Records: 6 Number of Pages: 1